On Invalid Date, Telesis Bio (NASDAQ: TBIO) reported Q4 2022 earnings per share (EPS) of -$0.28, up 9.68% year over year. Total Telesis Bio earnings for the quarter were -$8.13 million. In the same quarter last year, Telesis Bio's earnings per share (EPS) was -$0.31.
On Invalid Date, Telesis Bio (NASDAQ: TBIO) reported Q4 2022 revenue of $9.47 million up 207.63% year over year. In the same quarter last year, Telesis Bio's revenue was $3.08 million.
What was TBIO's revenue growth in the past year?
As of Q1 2023, Telesis Bio's revenue has grown 148.44% year over year. This is 141.12 percentage points higher than the US Medical Devices industry revenue growth rate of 7.32%. Telesis Bio's revenue in the past year totalled $27.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.